You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information

AMR leads to longer hospital stays, increased mortality, and higher medical costs.

2 Million
The annual number of patients with AMR infections in the U.S.2

$39 Million
Extra healthcare costs and productivity losses in the U.S. per year due to AMR2

The annual number of deaths in the U.S. caused by AMR2

Better Antibiotic Stewardship
with GeneXpert®

When today’s healthcare providers are able to quickly identify whether an infection is present and if it is drug-resistant, we will finally be able to move beyond trial and error. On-demand molecular diagnostics have the potential to help you identify resistance in minutes, rather than days. Cepheid’s GeneXpert® System helps those on the frontlines of resistance prevent the inappropriate use of antimicrobials and preserve our antibiotic weapons―now and in the future. Click here to download our antimicrobial stewardship brochure.


Download Antibiotic Stewardship Brochure

Antimicrobial stewardship interventions with rapid molecular diagnostics:

Shortened hospital length of
stay by 2.5 days3

Decreased lethal bloodstream
infections in patients by 36%3

Reduced time to effective
therapy by 5 hours3


Related White Papers & Webinars

1. World Health Organization. “Antimicrobial resistance: global report on surveillance.” June, 2014.

2. CDC. Antibiotic resistance threats in the United States, 2013. Accessed 12 July 2018.

3. CDC at Work: Preventing Healthcare-Associated Infections. Accessed 12 July 2018.

Connect To Better Outcomes

Request Info
Back to Top